cancer chemotherapy
Cancer Chemotherapy
$235.00 Original price was: $235.00.$4.99Current price is: $4.99. Add to cart
Sale!

Cancer Chemotherapy

Original price was: $235.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Chemical Warfare: Cancer Chemotherapy

Administering chemotherapy is the deliberate introduction of highly toxic, DNA-shredding poisons into a human vein. The goal is to aggressively kill the rapidly dividing cancer cells before the poison catastrophically destroys the patient’s bone marrow, heart, or kidneys. Cancer Chemotherapy is the brutally precise, universally respected clinical master text detailing exactly how to execute this high-wire act of medical pharmacology. This volume provides the absolute, non-negotiable blueprints required to dose, deliver, and manage systemic cytotoxic therapy.

Mastering the Alkylating Agents

The core philosophy of this text is the mechanism of lethal cross-linking. The authors aggressively detail the pharmacology of drugs like Cyclophosphamide. It dictates exactly how these brutal molecules physically weld the two strands of the cancer cell’s DNA together, so that when the cell attempts to replicate and divide, the DNA violently tears itself apart, forcing the cell to instantly commit suicide.

Navigating the Dose-Limiting Toxicity

The book provides a masterclass in managing the collateral damage. It dictates the exact clinical pathways for rescuing the patient. It rigorously catalogs the terrifying side effects of every major drug—from the irreversible heart failure caused by Doxorubicin to the massive, hemorrhagic destruction of the bladder caused by Ifosfamide—and dictates the exact pharmacological antidotes (like Dexrazoxane and Mesna) required to prevent patient death.

Frequently Asked Questions (FAQs)

Is this a book about alternative, holistic remedies for cancer?
Absolutely not. It is a strictly *allopathic, pharmacological, and clinical oncology manual* based entirely on FDA-approved cytotoxic agents and rigorous clinical trial data.

Who is the primary audience?
It is the absolute, mandatory daily reference for Medical Oncologists, Oncology Pharmacists, Hematologists, and Advanced Practice Oncology Nurses.